NPS Expects to Net $93M+ in Fourth Financing in 20 Months
By Tom Wall
Friday, April 15, 2011
NPS Pharmaceuticals Inc. expects to net $93 million in an underwritten public offering of 11 million shares at $9 a share, about a 2.6 percent discount over the previous day's closing price. It is the Bedminster, N.J.-company's fourth major financing in the past 20 months, for a total of more than $230 million during that period.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.